April 2016

Family-centered empowerment model may improve physical and mental health following MI ()
FDA approves first generic version of Crestor ()
Subgroup analysis shows IN.PACT Admiral drug-coated balloon is effective in females and diabetics ()
Bleeding rates following PCI vary depending on hospital, patient factors ()
Journals retract two articles with similar text regarding coronary artery disease in China ()
Abbott CEO, CFO discuss $25 billion deal for St. Jude Medical ()
Sales of oral heart failure medication fall short of expectations ()
Abbott agrees to acquire St. Jude Medical in $25 billion deal ()
Atrial fibrillation may contribute to worse outcomes among patients undergoing TAVR ()
Lobbyist tells healthcare industry to fight against potential bans on pharma advertising ()
Boston Scientific’s revenue, profit increases in first quarter ()
Registry analysis shows low rates of all-cause mortality and intracranial bleeding with warfarin ()
Strong TAVR sales help Edwards Lifesciences increase revenue in first quarter ()
Cardiologist accused of Medicare fraud declares bankruptcy ()
U.S. Soccer CEO undergoes successful heart transplant surgery ()
Patients with diabetes undergoing PCI have similar outcomes whether or not they receive insulin ()
FDA approves MR-conditional pacing system for patients with bradycardia ()
Real-world study shows Reveal LINQ insertable cardiac monitor detects atrial fibrillation at high rate ()
Palmaz Scientific faces accusations of misleading investors ()
Score helps predict 30-day readmission or death from heart failure ()
St. Jude Medical’s revenue, earnings increase in first quarter ()
Budoff wins SCCT’s 2016 gold medal award ()
Loneliness and isolation lead to a 30% increased risk in heart disease, stroke ()
Sales of PCSK9 inhibitors fall short of expectations ()
ACC president asks colleagues to embrace changing healthcare industry ()
Auris Surgical Robotics agrees to acquire Hansen Medical for $80 million ()
Real-world analysis shows Xarelto reduces ischemic stroke and intracranial hemorrhage versus warfarin ()
Disclosing coronary heart disease risk improves shared decision making on statin therapy ()
Technical and clinical success rates of PCIs for CTOs increase over time ()
Preventive medicine remains a major priority, challenge for healthcare leaders ()
Death of a partner may increase risk of atrial fibrillation ()
Boston Scientific Announces CE Mark For MRI Labeling Of Emblem™ S-ICD Systems ()
Obesity in adolescence is associated with increased risk of death from cardiovascular causes in adulthood ()
Expert Roundtable: Optimizing Your Structural Heart Disease Program ()
ACC, other medical societies express views on MACRA and new payment models ()
Stroke mortality and readmissions depend on various factors ()
Program reduces readmissions by nearly 10 percent among high-risk Medicare patients ()
Tackling CV Inventory Management Challenges with Automation & Operational Excellence ()
Small pharmaceutical company plans on reviving failed cholesterol medication ()
Minimally invasive mitral valve surgery appears to be superior to conventional sternotomy ()
Athletes with cardiovascular disease to compete in World Heart Games in May ()
FDA withdraws approvals of niacin and fenofibric acid in combination with statins ()
Survey finds most physicians do not understand FDA approval process ()
Patients transferred for acute stroke care are younger and have higher stroke severity ()
Living near a highway may increase cardiovascular disease risk ()
Prediction score may help identify patients who benefit from dual antiplatelet therapy following PCI ()
Medtronic provides update on tender offer ()
Mean price of insulin increases nearly 200% from 2002 to 2013 ()
ACC notifies 1,400 institutions of potential data breach ()
European Society of Cardiology cancels conference in Turkey ()
CMS proposes ban on Theranos founder and president ()
CMS announces facilities in Mississippi and Georgia meet standards for carotid artery stenting ()
ACC survey finds fewer than 20% of cardiologists are women ()
ACC.16: CABG reduces long-term rates of death and hospitalizations in patients with ischemic cardiomyopathy ()
Former NEJM editor calls for financial conflicts of interest disclosures ()
ACC.16: Intermediate-risk patients have low mortality, stroke rates with the Sapien 3 TAVR valve ()
ACC.16: Mobile health intervention helps participants increase exercise and lose weight ()
ACC.16: Shared decision-making tool helps inform patients with chest pain about their risks and options ()
Dexcom recalls glucose monitoring systems ()
USPSTF releases update on aspirin use to prevent cardiovascular disease and colorectal cancer ()
FDA commissioner calls for changes in medical education ()
ACC, AHA, AGS recommend trials examine older adults with cardiovascular disease ()
Vascular Solutions recalls Guardian II hemostasis valves ()
Verseon presents further trial data on the low bleeding risk of its family of preclinical anti-coagulant drugs at BioEurope conference ()
Boston Scientific recalls Fetch 2 aspiration catheter ()
New England Journal of Medicine editor-in-chief defends publication ()
Jury rules in favor of Abbott in whistleblower lawsuit ()
ACC.16: Evolocumab lowers LDL cholesterol significantly more than ezetimibe in statin-intolerant patients ()
ACC.16: FDA commissioner discusses evidence-based medicine, changing healthcare industry ()
Medication costs soar in the U.S. ()
FDA approves Impella heart pumps to treat ongoing cardiogenic shock ()
FDA warns of heart failure risk in medications that contain saxagliptin and alogliptin ()
Medtronic releases statement defending Covidien deal in wake of proposed tax regulations ()
Lund University Hospital Study Validates Improved Long-Term Clinical Outcomes Using Stereotaxis Technology ()
Registry analysis provides real-world data on TAVR outcomes ()
FDA approves the Micra miniature leadless pacing system ()
ACC.16: TAVR outcomes improve with increasing volume of procedures ()
Hartford HealthCare Announces Heart and Vascular Institute Appointments ()
ACC.16: TAVR with the Sapien XT valve is non-inferior to surgery at two years ()
ACC.16: ‘Prevention’ is word of the day as ACC conference kicks off in Chicago ()
ACC.16: Chazal becomes ACC President ()
ACC.16: Strategies may help hospitals reduce readmissions following PCI ()
Medtronic CoreValve® System Maintains Survival Advantages Over Surgery in High Risk Aortic Stenosis Patients at Three Years ()
ScImage to Launch PicomSentry at ACC ()
World obesity expanding even as some regions continue to starve ()
ACC.16: PET/CT study links stress to heightened risk of cardiovascular disease ()
CMS report finds Theranos blood testing devices often fail to meet company’s standards ()